Browse life science companies in Cambridge, home to one of Europe's leading biotechnology and life science ecosystems.
NGS-based platform for off-target gene editing detection and characterisation
Broken String Biosciences is a Cambridge-based genomics company developing tools to improve the safety of cell and gene therapies. Its platform uses next-generation sequencing to…
Neuroactive therapeutics through genetic engineering of fungi and plants
Empyrean Neuroscience is a biopharma company that uses genetic engineering of fungi and plants to develop small molecule therapeutics for neuropsychiatric and neurologic…
ML-enabled nanoparticle delivery platform for targeted therapeutics
Vector Bioscience is a University of Cambridge spin-out developing a machine learning-enabled drug delivery platform based on metal-organic framework nanoparticles. The technology…
Cloud-based informatics platform for drug discovery data management
Collaborative Drug Discovery (CDD) is a software company providing a cloud-based informatics platform for drug discovery research. Its flagship product enables scientists to…
Preclinical CRO delivering integrated drug discovery and development services
Selvita is a contract research organisation providing integrated drug discovery and development services to pharmaceutical and biotechnology companies. The company supports…
Integrated outsourced drug discovery and development platform
RxCelerate is a contract research organisation providing fully integrated drug discovery and development services to pharmaceutical and biotech companies. Based at Babraham…
AI-driven combinatorial chemistry platform for next-generation RNA therapeutics
Eleven Therapeutics is a biotechnology company developing next-generation RNA therapeutics by combining combinatorial chemistry with artificial intelligence to map the vast…
AI-driven drug discovery targeting necrosis and age-related disease
LinkGevity is a preclinical-stage biotechnology company developing anti-necrotic therapeutics for age-related and degenerative diseases. Founded in 2023 and based at Babraham…
Tumour-activated peptide drug conjugates for targeted oncology
Avacta Therapeutics is a clinical-stage biotechnology company developing peptide drug conjugates designed to deliver toxic chemotherapy payloads selectively within the tumour…
Small-molecule anti-biofilm add-on therapy for antibiotic-resistant urinary tract infections
BioTryp Therapeutics is a UK-based drug discovery company developing small-molecule therapies that inhibit bacterial biofilm formation. The company's lead programme is an oral…
Rare and serious disease therapeutics with Cambridge R&D hub
Insmed is a US biopharmaceutical company with commercial-stage and late-pipeline products spanning respiratory, inflammatory and rare neurological diseases. Its Cambridge facility…
Europe's oldest science park, anchored by Cambridge University
Cambridge Science Park is Europe's first science park, founded by Trinity College, Cambridge in 1970 and spanning 152 acres on the northern edge of the city. Trinity College…